SonoThera raises $125 million to run clinical trials of its gene treatment for Duchenne muscular dystrophy.
The Collaborative Trajectory Analysis Project (cTAP) announces the publication of a novel, validated prognostic score for predicting the loss of ambulation (LoA) in patients with Duchenne muscular ...
Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher Capricor Therapeutics (NASDAQ:CAPR) executives said the company ...
PARENTS of children who suffer from a rare muscular condition have hailed a “momentous day” after the HSE gave the green ...
A new treatment platform developed by researchers at the University of Texas MD Anderson Cancer Center was able to deliver ...
Health Canada Priority Review targets an expedited 180-day review period for givinostat, reflecting Italfarmaco’s commitment ...
GEn1E Lifesciences Inc., a Phase 2 clinical-stage biotechnology company advancing AI-driven precision medicines for ...
The face we present to the world is constantly changing as different combinations of its 42 muscles contract and contort it. Humans can produce thousands of distinct facial expressions – including 19 ...
The ‘Protect Iliauni’ movement says GEL 2 million has been raised to support children with Duchenne muscular dystrophy. In a ...
Parents of children with Duchenne muscular dystrophy who met with Prime Minister Irakli Kobakhidze at the Government ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results